- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Tarrytown Today
By the People, for the People
Hamilton Wealth LLC Acquires New Stake in Regeneron Pharmaceuticals
Institutional investor adds 12,581 shares of biotech company to portfolio
Mar. 16, 2026 at 11:21am
Got story updates? Submit your updates here. ›
Hamilton Wealth LLC, an institutional investor, has acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in the third quarter, according to a recent SEC filing. The firm purchased 12,581 shares of the biopharmaceutical company's stock, valued at approximately $7,074,000.
Why it matters
Regeneron Pharmaceuticals is a prominent biotech company known for its innovative drug discovery technologies and pipeline of biologic therapies. The acquisition of a new stake by Hamilton Wealth LLC, a respected institutional investor, suggests confidence in the company's future growth and performance.
The details
According to the 13F filing, Hamilton Wealth LLC's new position in Regeneron Pharmaceuticals comprises approximately 1.5% of the firm's total holdings, making it the 21st largest position in their portfolio. The purchase of 12,581 shares was likely driven by the company's strong financial performance, pipeline advancements, and potential for future growth in the biopharmaceutical industry.
- Hamilton Wealth LLC acquired the new position in Regeneron Pharmaceuticals during the third quarter of the year.
The players
Hamilton Wealth LLC
An institutional investor that has acquired a new position in shares of Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
A U.S.-based biotechnology company that focuses on discovering, developing, manufacturing, and commercializing medicines for serious medical conditions.
The takeaway
The acquisition of a new stake in Regeneron Pharmaceuticals by a respected institutional investor like Hamilton Wealth LLC suggests confidence in the company's long-term growth potential within the biopharmaceutical industry. This move highlights the continued interest and investment in innovative biotech firms with promising drug pipelines and technologies.
